Logo Logo
Switch Language to German

Modest, D. P.; Reinacher-Schick, A.; Stintzing, S.; Giessen, C.; Tannapfel, A.; Laubender, Rüdiger P.; Brodowicz, T.; Knittelfelder, R.; Vrbanec, D.; Schmiegel, W.; Heinemann, V. and Zielinski, C. C. (2012): Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis. In: Anticancer Drugs, Vol. 23, No. 6: pp. 666-673

Full text not available from 'Open Access LMU'.

Actions (login required)

View Item View Item